Rabia Gurses Ozden

Rabia Gurses Ozden, MD, is an experienced medical executive with a strong background in clinical development and glaucoma. Currently serving as Chief Medical Officer and Board Member at Adverum Biotechnologies, Rabia has held similar roles at Ocular Therapeutix, Inc. and NIGHTSTAR THERAPEUTICS, and has also worked as Chief Development Officer at Akouos. Rabia's expertise in glaucoma was honed during postgraduate fellowships at The New York Eye and Ear Infirmary, where participation in advanced clinical training in glaucoma took place from 1999 to 2001. Additionally, consulting experience includes work with Clementia Pharmaceuticals Inc.